Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

  • Post author:
  • Post category:uncategorized

Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited.